This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2021 Mar 10;39(8):867-869.

doi: 10.1200/JCO.20.03523. Epub 2021 Jan 25.

Incorporating VEGF Blockade Into a Shifting Treatment Paradigm for Mucosal Melanoma

Alexander N Shoushtari¹

Affiliations

PMID: 33492992
DOI: 10.1200/JCO.20.03523

Editorial

Incorporating VEGF Blockade Into a Shifting Treatment Paradigm for Mucosal Melanoma

Alexander N Shoushtari. J Clin Oncol. 2021.

. 2021 Mar 10;39(8):867-869.

doi: 10.1200/JCO.20.03523. Epub 2021 Jan 25.

Author

Alexander N Shoushtari¹

Affiliation

¹ Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY.

PMID: 33492992
DOI: 10.1200/JCO.20.03523

No abstract available

PubMed Disclaimer

Comment on

Randomized Phase II Study of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Mucosal Melanoma.
Yan X, Sheng X, Chi Z, Si L, Cui C, Kong Y, Tang B, Mao L, Wang X, Lian B, Li S, Bai X, Zhou L, Dai J, Yao H, Guo J. Yan X, et al. J Clin Oncol. 2021 Mar 10;39(8):881-889. doi: 10.1200/JCO.20.00902. Epub 2021 Jan 14. J Clin Oncol. 2021. PMID: 33444116 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information